biological products

FDA okays new diabetes, asthma drugsFDA recently approved a new diabetes medication, as well as a drug to treat severe asthma.
Biosimilars' savings may reach $100 billion by 2020The use of biosimilars in the European Union and the United States may yield huge savings to healthcare systems over the next five years
[BLOG]: 5 things you need to know about biosimilarsThe first biosimilar product was approved this spring. Pharmacists will want to familiarize themselves with this new class of therapies. Below are the five top things that a pharmacist should know about biosimilars.
FDA panel backs approval of GSK's mepolizumab for severe asthmaThe FDA’s Pulmonary-Allergy Drugs Advisory Committee recently recommended approval of GlaxoSmithKline Plc's drug mepolizumab (Nucala) for severe asthma patients 18 and older.
FDA updates labeling of drugs for pregnant and lactating womenThe US Food and Drug Administration (FDA) recently issued a final rule altering how the labels for physicians on prescription drugs and biological products provide information for pregnant and breastfeeding women.
California governor vetoes biosimilar substitution billWith pharmacy industry bodies, labor unions, and special interest groups arrayed against the bill, Governor Brown returned the legislation to the State Senate unsigned.